The 3DP Lumbar Interbodies are additively manufactured from titanium alloy using a proprietary design.The science behind our proprietary SemaFour™ lattice technology was rigorously researched to provide the best possible osteogenic potential. The SemaFour™ lattice technology is characterized by the optimization of four key facets: Surface Roughness, Surface Energy, Wettability, and Pore Size.
These design elements were tailored specifically to aid the healing cascade and to promote the fusion process. End-users will also be thrilled by the low-modulus, highly porous, osteoconductive nature of our 3D-printed Interbodies. The ALIF portion of this system is currently available for use – all other approaches are available upon request.Geometric Optimization was developed to accelerate angiogenesis and osteogenesis through pore-size, porosity, pore-interconnectedness, and stiffness.
Benefits:
- Surface characteristics designed and optimized for cell & protein adhesion, cell differentiation, and osteoconduction
- Tailored Stiffness allows for load-sharing between implant and the native bone.
- Highly porous: Every 3DP Lumbar Interbody has greater than 50% porosity.
- Enables packing of osteoinductive autograft.
- Pore sizes that were designed and optimized for accelerating angiogenesis
- Large side windows allow for better post-operative assessment of fusion (reduced scatter and halo observed on fluoroscopic imaging).
To learn more contact us at [email protected]
For more information please visit: http://www.genesysspine.com
About Genesys Spine
Founded in December of 2009, Genesys Spine’s mission was to bring a suite of medical implants and instruments with novel characteristics into a mature spinal fusion market. Since that time, Genesys has released four new FDA cleared product lines with several other products in various stages of the design and development cycle. Genesys has also developed several proprietary instruments to aid in the use of its products. All of Genesys’ inaugural products including our system specific instruments, have garnered very positive feedback from the marketplace. Our implants, with their proprietary features, all remain within existing parameters for today’s current reimbursement codes.